News
Featured by Imperial College London
Our parent company was recently featured by Imperial College London for being a successful spin-out, recognized for our cutting-edge advancements in cancer diagnostics and our significant contributions to personalized cancer treatment.
Featured in the Financial Times
Our parent company was featured by the Financial Times for our partnership with the public company Physiomics, a leader in computational systems biology. Together, we are revolutionizing cancer care by combining advanced microfluidics and autofluorescence imaging with Physiomics' expertise in predictive modeling to drive the future of precision medicine.